The Acidaminococcus sp. Cas12a nuclease recognizes GTTV and GCTV as non-canonical PAMs.


Journal

FEMS microbiology letters
ISSN: 1574-6968
Titre abrégé: FEMS Microbiol Lett
Pays: England
ID NLM: 7705721

Informations de publication

Date de publication:
01 04 2019
Historique:
received: 23 12 2018
accepted: 19 04 2019
pubmed: 21 4 2019
medline: 4 6 2020
entrez: 21 4 2019
Statut: ppublish

Résumé

The clustered regularly interspaced short palindromic repeat (CRISPR)-associated (Cas) nuclease Acidaminococcus sp. Cas12a (AsCas12a, also known as AsCpf1) has become a popular alternative to Cas9 for genome editing and other applications. AsCas12a has been associated with a TTTV protospacer-adjacent motif (PAM) as part of target recognition. Using a cell-free transcription-translation (TXTL)-based PAM screen, we discovered that AsCas12a can also recognize GTTV and, to a lesser degree, GCTV motifs. Validation experiments involving DNA cleavage in TXTL, plasmid clearance in Escherichia coli, and indel formation in mammalian cells showed that AsCas12a was able to recognize these motifs, with the GTTV motif resulting in higher cleavage efficiency compared to the GCTV motif. We also observed that the -5 position influenced the activity of DNA cleavage in TXTL and in E. coli, with a C at this position resulting in the lowest activity. Together, these results show that wild-type AsCas12a can recognize non-canonical GTTV and GCTV motifs and exemplify why the range of PAMs recognized by Cas nucleases are poorly captured with a consensus sequence.

Identifiants

pubmed: 31004485
pii: 5475644
doi: 10.1093/femsle/fnz085
pmc: PMC6604746
pii:
doi:

Substances chimiques

Bacterial Proteins 0
CRISPR-Associated Proteins 0
Cas12a protein EC 3.1.-
Endodeoxyribonucleases EC 3.1.-
Endonucleases EC 3.1.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM119561
Pays : United States

Informations de copyright

© FEMS 2019.

Références

Science. 2007 Mar 23;315(5819):1709-12
pubmed: 17379808
J Bacteriol. 2008 Feb;190(4):1401-12
pubmed: 18065539
J Bacteriol. 2008 Feb;190(4):1390-400
pubmed: 18065545
Science. 2008 Aug 15;321(5891):960-4
pubmed: 18703739
Microbiology. 2009 Mar;155(Pt 3):733-40
pubmed: 19246744
Cell. 2009 Nov 25;139(5):945-56
pubmed: 19945378
Nature. 2010 Nov 4;468(7320):67-71
pubmed: 21048762
Nature. 2011 Mar 31;471(7340):602-7
pubmed: 21455174
Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10092-7
pubmed: 21536913
Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10098-103
pubmed: 21646539
Mol Cell. 2012 Jun 8;46(5):595-605
pubmed: 22521689
Science. 2012 Aug 17;337(6096):816-21
pubmed: 22745249
Nat Biotechnol. 2013 Mar;31(3):233-9
pubmed: 23360965
Nat Biotechnol. 2013 Sep;31(9):827-32
pubmed: 23873081
Nat Methods. 2013 Nov;10(11):1116-21
pubmed: 24076762
Sci Rep. 2014 Jun 23;4:5405
pubmed: 24956376
Nucleic Acids Res. 2014 Dec 16;42(22):e168
pubmed: 25300484
Nature. 2015 Jul 23;523(7561):481-5
pubmed: 26098369
Cell. 2015 Oct 22;163(3):759-71
pubmed: 26422227
Nature. 2016 Jan 28;529(7587):490-5
pubmed: 26735016
Mol Ther. 2016 Mar;24(3):475-87
pubmed: 26750397
ACS Synth Biol. 2016 Apr 15;5(4):344-55
pubmed: 26818434
Mol Cell. 2016 Apr 7;62(1):137-47
pubmed: 27041224
Nat Biotechnol. 2016 Aug;34(8):863-8
pubmed: 27272384
Nat Biotechnol. 2016 Sep 08;34(9):933-941
pubmed: 27606440
J Mol Biol. 2017 Jan 20;429(2):177-191
pubmed: 27916599
Nat Biotechnol. 2017 Jan;35(1):31-34
pubmed: 27918548
Nat Methods. 2017 Feb;14(2):153-159
pubmed: 27992409
Nat Biotechnol. 2017 Aug;35(8):789-792
pubmed: 28581492
Mol Cell. 2017 Aug 17;67(4):633-645.e3
pubmed: 28781234
Nucleic Acids Res. 2017 Nov 2;45(19):11295-11304
pubmed: 28977650
Nat Methods. 2017 Dec;14(12):1163-1166
pubmed: 29083402
Mol Cell. 2018 Jan 4;69(1):146-157.e3
pubmed: 29304331
Science. 2018 Apr 27;360(6387):436-439
pubmed: 29449511
Methods. 2018 Jul 1;143:48-57
pubmed: 29486239
Nature. 2018 Apr 5;556(7699):57-63
pubmed: 29512652
Science. 2018 Apr 27;360(6387):381-382
pubmed: 29700254
Nat Commun. 2018 May 15;9(1):1911
pubmed: 29765029
Science. 2018 Sep 21;361(6408):1259-1262
pubmed: 30166441
Nucleic Acids Res. 2019 Feb 20;47(3):e13
pubmed: 30462300
Cell Rep. 2018 Dec 18;25(12):3262-3272.e3
pubmed: 30566855
Trends Biotechnol. 2019 Jul;37(7):730-743
pubmed: 30654914
Nat Biotechnol. 2019 Mar;37(3):276-282
pubmed: 30742127

Auteurs

Thomas Jacobsen (T)

Department of Chemical and Biomolecular Engineering, North Carolina State University, 911 Partners Way, Raleigh, NC 27695, USA.

Chunyu Liao (C)

Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Centre for Infection Research (HZI), Josef-Schnedier-Str. 2, 97080 Würzburg, Germany.

Chase L Beisel (CL)

Department of Chemical and Biomolecular Engineering, North Carolina State University, 911 Partners Way, Raleigh, NC 27695, USA.
Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Centre for Infection Research (HZI), Josef-Schnedier-Str. 2, 97080 Würzburg, Germany.
Medical Faculty, University of Würzburg, Josef-Schneider-Str. 2, 97080 Würzburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH